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ABSTRACT
Introduction: Serious adverse outcomes for people
with dementia include institutionalisation,
hospitalisation, death, development of behavioural and
psychiatric symptoms, and reduced quality of life. The
quality of the relationship between the person with
dementia and their informal/family carer is thought to
affect the risk of these outcomes. However, little is
known about which aspects of relationship quality are
important, or how they affect outcomes for people with
dementia.
Methods and analysis: This will be a systematic
review of the literature. Electronic databases MEDLINE,
EMBASE, Web of Science, PsycInfo, the Cochrane
Database, ALOIS and OpenGrey will be searched from
inception. 2 independent reviewers will screen results
for eligibility with standardised criteria. Data will be
extracted for relevant studies, and information on the
associations between relationship quality and dementia
outcomes will be synthesised. Meta-analysis will be
performed if possible to calculate pooled effect sizes.
Narrative synthesis will be performed if study
heterogeneity rules out meta-analysis.
Ethics and dissemination: Ethical review is not
necessary as this review summarises data from
previous studies. Results will be disseminated via peer-
reviewed publication. Results will also be disseminated
to a patient and public involvement group and an
expert panel for their views on the findings and
implications for future work.
Trial registration number: CRD42015020518.
INTRODUCTION
The WHO and International Classiﬁcation of
Diseases V.10 (ICD-10) deﬁne dementia as “a
syndrome due to disease of the brain, usually
of a chronic or progressive nature, in which
there is disturbance of multiple higher cor-
tical functions, including memory, thinking,
orientation, comprehension, calculation,
learning capacity, language, and judgement.
Consciousness is not clouded. The impair-
ments of cognitive function are commonly
accompanied, and occasionally preceded, by
deterioration in emotional control, social
behaviour, or motivation. This syndrome
occurs in Alzheimer disease, in cerebrovascu-
lar disease, and in other conditions primarily
or secondarily affecting the brain.”1
Dementia is considered a major public
health problem and is a recognised priority
for the UK and other governments. It is a
leading cause of disability and dependency in
older people2 with high social and economic
costs from medical and health and social
care, informal care needs, and lost productiv-
ity. It is estimated to be the most expensive of
any mental health or brain disorder in the
UK,3 more expensive than heart disease,
stroke or cancer.4 It accounts for 1% of total
worldwide gross domestic product (GDP; up
to 1.24% of total GDP in high-income coun-
tries).5 Worldwide, between 5% and 7% of
people over 60 have dementia (more than 35
million people in 2010) with numbers pre-
dicted to double every 20 years.6–8 In the UK,
in 2015, there are thought to be over 856 700
people with dementia, affecting 1 in every 14
people over age 65.7
Currently, little is known about options for
prevention, and medical treatment only
reduces symptoms for a relatively small propor-
tion of the overall population. Interventions
focus largely on treatment and management of
Strengths and limitations of this study
▪ This systematic review will provide a comprehen-
sive evaluation of how the quality of the relation-
ship between patients with dementia and their
informal carers influences adverse outcomes for
patients.
▪ Results may help to inform future work to
support families affected by dementia, with the
aim of reducing or delaying institutionalisation.
▪ There may be significant heterogeneity in study
methodology which could limit the strength of
the conclusions we can draw from this review.
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symptoms as they arise, in order to minimise poor out-
comes. Institutionalisation (being placed in a care home)
is generally considered a ‘poor’ or last-ditch outcome to be
pursued only when independent living and informal care
are no longer sustainable. Most people with dementia wish
to live in their own home for as long as possible.9 Indeed,
continuing to do so has been found to support autonomy,
sense of identity, well-being and quality of life (QoL).10
Care home fees are also a serious ﬁnancial burden for
those living with dementia and their families.11 12 There
are also indirect costs to the public as fees are often supple-
mented via taxation. Unfortunately, it is not always possible
for the person with dementia to continue to live at home,
and a prime factor leading to the breakdown of care is that
their caregiver is no longer able to sustain the demands of
care giving.13 Thus, both in the UK and elsewhere, govern-
ment policy has emphasised the need to provide effective
support to families in order to help them cope in the
expectation that this would delay, and in some cases,
prevent, institutionalisation. At the same time, recent
media attention on poor standards of care, negligence and
abuse in some care homes has generated serious concerns
about placing loved ones, or being placed oneself in a care
home.14–16
There is a growing evidence base linking relationship
factors (such as amount of interaction and intimacy, and
coping strategies) to outcomes both for people with
dementia and for their carers. The quality of the
patient–carer relationship has been associated with the
likelihood of institutionalisation as well as the rate of
decline, stress levels and QoL of people with demen-
tia.17–26 Reviews of interventions suggest that optimising
aspects of the patient–carer relationship could poten-
tially improve outcomes in dementia,27–30 but these are
likely to be most effective if we can identify and target
those families at high risk of poor outcomes.
This review will evaluate the evidence on how the
quality of the relationship between a person with
dementia and their carer affects the patient’s risk of
institutionalisation, hospitalisation, development of
behavioural and psychiatric symptoms of dementia
(BPSD/challenging behaviour), QoL, and death.
METHODS AND ANALYSIS
A somewhat ﬂexible approach will be necessary for this
review, as it is difﬁcult to know in advance the nature of
the studies and data that may be available. We will
clearly document and justify any decisions made regard-
ing amendments to the inclusion/exclusion criteria and
synthesis plan proposed in this protocol, should they
become necessary. The details below reﬂect the planned
methods at the outset of the review.
Registration
This review is registered with the PROSPERO
International Prospective Register of Systematic
Reviews,31 registration number CRD42015020518. The
protocol is reported in line with recommendations of
the PRISMA-P statement (Preferred Reporting Items for
Systematic Review and Meta-Analysis Protocols).32
Publication will be reported in line with the PRISMA
statement.33 Protocol amendments will be updated on
PROSPERO.
Inclusion criteria
Study type: We plan to include cohort studies as the most
robust methodology for the research question. However,
at the screening stage of the review, we will also record
case–control and cross-sectional studies. If the synthesis
of cohort studies alone does not yield a sufﬁcient body
of evidence to draw any useful conclusions, we will at
that stage cautiously consider including case–control
and cross-sectional studies. Intervention studies would
be included if they speciﬁcally report data on the asso-
ciations of exposures and outcomes for the control
group (eg, a cohort study nested within a randomised
controlled trial (RCT)). Relevant systematic reviews will
be obtained and used as a means of identifying add-
itional primary studies. Case reports, qualitative studies,
cost-effectiveness studies, group-level/ecological studies
and editorials will be excluded. Conference proceedings
will be included if they contain sufﬁcient data to assess
inclusion and extract results.
Population: The population of interest is people with
dementia and their informal/unpaid carer(s). Carer(s)
may be a spouse, child, other family member, or non-
family such as a friend or neighbour. Professional paid
carers are excluded as their relationship with a patient
with dementia is expected to be qualitatively different.
All types of dementia will be included. Alzheimer’s, vas-
cular dementia, mixed dementia, frontotemporal
dementia and dementia with Lewy bodies are antici-
pated to be the most common. Studies on patients with
dementia in Parkinson’s, Huntington’s, Creutzfeldt-
Jakob Disease (CJD), Wernicke-Korsakoff syndrome and
other conditions will be included if it is explicit that the
population studied also have dementia. Studies of
people with mild cognitive impairment will be excluded.
Studies involving mixed populations where only a sub-
group is eligible will only be included if stratiﬁed sub-
group results are available for the eligible subgroup. If
subgroup-speciﬁc results are not available, a decision will
be made via consultation with content and methodo-
logical expert collaborators as to the likely effect on
results of inclusion of the non-relevant groups. Where
the effect is judged to be minimal, the study may be
included and contamination issues discussed.
Case-by-case decisions will be added to the protocol to
serve as a precedent for future cases.
Exposures/risk factors studied: Studies will be included if
they measure an element of the quality of relationship
between the person with dementia and their carer.
Amount of contact, closeness, attachment, expressed
emotion and coping style are primary exposures of inter-
est. Measures of relationship quality prior to dementia
2 Edwards HB, et al. BMJ Open 2016;6:e010835. doi:10.1136/bmjopen-2015-010835
Open Access
group.bmj.com on April 6, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
onset and concurrently with dementia will both be
included, although as far as possible, these will be ana-
lysed separately as relationships are expected to change
as a result of dementia.34
Studies speciﬁcally focused on carer abuse, such as
those that only include participants who are in abusive
relationships (as deﬁned by study authors), will be
excluded. The rationale is that abuse is an ‘extreme’
dimension of relationship quality belonging to a differ-
ent area of research (‘elder abuse’, which tends to focus
on long-term abusive relationships and in the broader
context of ageing, and does not focus speciﬁcally on
dementia). It has also been dealt with elsewhere.35 36
Studies in which participants in abusive relationships
are included alongside participants in non-abusive rela-
tionships, which are also exploring our speciﬁed eligible
exposures (and outcomes) of interest, will be included
(eg, studies comparing risk of institutionalisation in par-
ticipants in abusive relationships vs those in non-abusive
relationships).
Outcomes: Outcomes of interest are for the person with
dementia. The primary outcome is institutionalisation,
that is, being placed in a care home/nursing home.
Secondary outcomes are: death, acute or psychiatric
hospitalisation, QoL, and development/progression of
BPSD (also called ‘challenging behaviour’, which
includes, eg, depression, anxiety, agitation, aggression
and psychosis). Studies with BPSD/challenging behav-
iour or QoL as outcomes must use validated assessment
tools.
There are no geographical or language restrictions on
included studies. In cases where the full text is not avail-
able in English, attempts will be made to extract relevant
data from the abstract (usually available in English) and
results tables. Any cases where this is not possible will be
reported. There are no date restrictions on inclusion; all
databases will be searched from inception onwards.
Search methods
A search strategy has been developed by an information
scientist/research librarian (AR) in collaboration with
content experts (RC and SC) who advised on relevant
studies. Electronic databases MEDLINE, EMBASE, Web
of Science, PsycInfo, The Cochrane Database and
OpenGrey will be searched (see online supplementary
material for the full search strategy). Bibliographies of
included reports and relevant reviews will be screened to
identify further potentially relevant reports. These will
be included or excluded following the screening process
described below.
Selection of studies
Selection of studies: Title and abstract of all identiﬁed
reports will be screened for relevance independently by
two reviewers and all potentially relevant reports will be
retrieved. Any discrepancies between the reviewers will
be resolved via discussion, with other team members
consulted where necessary. All retrieved papers will be
read in full and assessed for eligibility against a standar-
dised inclusion checklist applied by two reviewers inde-
pendently. Reasons for exclusion will be recorded for all
reports excluded at this stage. Discrepancies between
the reviewers will be resolved via discussion, with other
team members consulted where necessary.
Data management and extraction
All reports identiﬁed in the search will be saved into
Endnote X7 reference manager software, and after
removal of duplicates, exported into a bespoke-built
Microsoft Access database for management and screen-
ing. Data will be extracted onto a standardised electronic
data collection form within the Access database. This
form will be developed and piloted on ﬁve reports prior
to use in the review. A second reviewer will check data
extracted for errors and completeness. Checks will be
escalated if there is a high error rate.
The following information will be extracted: bibliographic
information, country of study, study design, sample size,
participant characteristics (eg, age, gender, type of demen-
tia, type of carer (eg, spouse, child, sibling)), exposures
(eg, closeness, attachment, emotional expression) and out-
comes (eg, institutionalisation, development of challen-
ging behaviour, QoL) measured, measurement methods
(eg, interview, survey, notes review, standardised psycho-
logical test), statistical methods, results, and authors’
conclusions.
Measures of effect/association: For dichotomous data,
data from 2×2 tables will be collected with associated
risk ratios or ORs and 95% CIs. For continuous data,
the mean difference between groups with 95% CIs will
be collected. Both adjusted and unadjusted results will
be collected where given.
Data synthesis
Characteristics of included studies will be presented as a
narrative summary or table, including study design,
aims, population, setting, assessments and outcomes. If
the data are too heterogeneous to pool, then narrative
synthesis will be used to present results. Studies will be
grouped by outcome, with descriptive text and tables
used to summarise the range of results. For each
outcome category, relationship factors would be
grouped together. For example, for the outcome ‘institu-
tionalisation’, we would present all results on the associ-
ation of attachment style with the risk of
institutionalisation, followed by the association of
expressed emotion with the risk of institutionalisation,
etc (The effect of these different exposures would not
be combined in meta-analysis.) Commentary will detail
how differences in methodologies used and potential
biases could be affecting each study’s results.
If there are a sufﬁcient number of studies with sufﬁ-
ciently homogeneous populations, exposures and out-
comes, data will be pooled and meta-analysis performed
to calculate summary measures of effect. A
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random-effects model is likely to be most appropriate to
allow for expected differences between studies.
The effect of relationship factors may plausibly vary by
subgroups, for example, type of relationship (spouse vs
parent–child vs other relative vs neighbour/friend),
type/severity of dementia and the cultural setting. If
there are sufﬁcient studies with these data, we will
perform subgroup analysis on these factors. If data
pooling and subgroup analysis is not appropriate, where
possible results for relevant subgroups will be reported
and interpreted separately.
We will investigate whether the conclusions are robust
to the exclusion of studies at high risk of bias. We plan
to formulate main conclusions based on results from
studies at low risk of bias.
Assessment of methodological quality and risk of bias
Study quality and risk of bias will be assessed using the
Newcastle-Ottawa scale.37 Part of this includes assess-
ment of whether studies have adequately adjusted for
confounding factors. Factors considered a priori poten-
tial confounders are age,24 gender,38 socioeconomic
status,39 ethnicity,40–42 dementia type,43 dementia sever-
ity,44 BPSD,45 carer comorbidity,46 employment status of
carer47 and alcohol consumption.48
Assessment of heterogeneity: Studies may be heteroge-
neous in a variety of ways including design factors, expo-
sures studied, methods of assessment, participant factors
(age, gender, ethnicity, carer type), setting (country, cul-
tural group, community vs institution) and dementia
type. This methodological and clinical heterogeneity will
be assessed by reviewers during the data extraction and
synthesis, and in reporting, we will comment on whether
studies adjusted for potential baseline confounding
factors.
If results allow, statistical heterogeneity will be
explored by visual assessment of study results presented
in a forest plot. Little overlap between CIs indicates het-
erogeneity. A χ2 statistic will be used to assess whether
differences in results are compatible with chance alone,
and I2 statistic to quantify the proportion of the total
variability in results estimated to be due to study-speciﬁc
heterogeneity, rather than random sampling error.
Roughly, I2 of 0–40% can be interpreted as little hetero-
geneity, 30–60% as moderate, 50–90% substantial and
75–100% as considerable heterogeneity.49
Assessment of reporting biases: Historically, funnel plots
have often been used as a method of assessing reporting
bias. However, current expert consensus indicates
caution in their use, as there are many possible alterna-
tive causes of funnel plot asymmetry, particularly in
observational studies.50 The circumstances where inter-
pretation of funnel plot results can be clearer (eg,
meta-analyses of prospectively registered RCT results) do
not apply to this review, so funnel plots will not be used
here. The potential inﬂuence of reporting bias will be
addressed in the Discussion section.
ETHICS AND DISSEMINATION
Ethical review is not necessary as this review summarises
data from previous studies. Results will be disseminated
via peer-reviewed publication. Results will also be disse-
minated to a patient and public involvement group and
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implications for future work.
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